Partial Opioid Agonist [EPC]

Partial Opioid Agonist [EPC] was reported 93918 times

Drugs of the Partial Opioid Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DRUG DELIVERY SYSTEM REMOVAL 106 0.8833
1 PLACENTAL HYPERTROPHY 23 0.5750
2 HEPATIC ENZYME 74 0.4966
3 ORAL ADMINISTRATION COMPLICATION 421 0.4527
4 INADEQUATE ANALGESIA 3056 0.3594
5 RHESUS INCOMPATIBILITY 34 0.2810
6 APPLICATION SITE ODOUR 38 0.2621
7 APPLICATION SITE PERSPIRATION 45 0.2601
8 FACET JOINT SYNDROME 733 0.2249
9 APPLICATION SITE RASH 3071 0.2231
10 AMAUROSIS FUGAX 193 0.1792
11 INJECTION SITE EROSION 60 0.1705
12 APPLICATION SITE DISCHARGE 188 0.1629
13 APPLICATION SITE SCAR 200 0.1597
14 APPLICATION SITE VESICLES 1026 0.1580
15 DRUG DETOXIFICATION 138 0.1544
16 PERIPHERAL VENOUS DISEASE 590 0.1443
17 DRUG EFFECT INCREASED 453 0.1432
18 APPLICATION SITE EROSION 184 0.1427
19 APPLICATION SITE BURN 700 0.1420
20 HYPOCHOLESTEROLAEMIA 50 0.1416
21 APPLICATION SITE IRRITATION 1713 0.1375
22 ONYCHOMADESIS 567 0.1350
23 DRUG SCREEN NEGATIVE 237 0.1346
24 BLEPHAROSPASM 844 0.1339
25 APPLICATION SITE REACTION 885 0.1257
26 BREAKTHROUGH PAIN 290 0.1253
27 RHEUMATIC FEVER 552 0.1237
28 DRUG WITHDRAWAL SYNDROME NEONATAL 1797 0.1212
29 BREAST CANCER STAGE III 782 0.1206
30 SWOLLEN JOINT COUNT 27 0.1080
31 DUODENAL ULCER PERFORATION 785 0.1055
32 APPLICATION SITE PRURITUS 2388 0.1051
33 OVERLAP SYNDROME 71 0.1014
34 DRUG LEVEL FLUCTUATING 89 0.1002
35 APPLICATION SITE DISCOLOURATION 402 0.0988
36 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 700 0.0976
37 PRODUCT ADHESION ISSUE 3452 0.0965
38 ONYCHOMYCOSIS 421 0.0959
39 SUBSTANCE USE DISORDER 303 0.0950
40 INJECTION SITE ULCER 89 0.0944
41 APPLICATION SITE URTICARIA 205 0.0912
42 LEARNING DISABILITY 468 0.0878
43 CENTRAL PAIN SYNDROME 22 0.0830
44 PRODUCT SOLUBILITY ABNORMAL 419 0.0829
45 DRUG WITHDRAWAL SYNDROME 7139 0.0813
46 APPLICATION SITE PUSTULES 29 0.0795
47 INFUSION SITE REACTION 236 0.0789
48 DRUG DEPENDENCE 12578 0.0781
49 MUSCLE INJURY 646 0.0779
50 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 41 0.0761
51 APPLICATION SITE DERMATITIS 70 0.0749
52 TOOTH EROSION 91 0.0743
53 FINGER DEFORMITY 360 0.0742
54 CENTRAL SLEEP APNOEA SYNDROME 24 0.0738
55 HELICOBACTER INFECTION 743 0.0722
56 FOLLICULITIS 748 0.0713
57 NAIL DISORDER 611 0.0698
58 LIP DRY 628 0.0691
59 APPLICATION SITE HYPERSENSITIVITY 83 0.0683
60 APPLICATION SITE ERYTHEMA 1777 0.0677
61 LIVE BIRTH 560 0.0669
62 APPLICATION SITE ULCER 47 0.0664
63 PEMPHIGUS 825 0.0659
64 HYPERCHOLESTEROLAEMIA 632 0.0654
65 BURSITIS 788 0.0649
66 TOXICITY TO VARIOUS AGENTS 10861 0.0643
67 C-REACTIVE PROTEIN ABNORMAL 410 0.0639
68 VISCERAL CONGESTION 32 0.0626
69 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35 0.0624
70 SUBSTANCE ABUSE 508 0.0623
71 ACCIDENTAL POISONING 84 0.0612
72 WOUND INFECTION 665 0.0607
73 C-REACTIVE PROTEIN 56 0.0604
74 LUPUS VULGARIS 76 0.0603
75 HAND DEFORMITY 768 0.0585
76 PRODUCT LABEL CONFUSION 336 0.0576
77 DRUG DIVERSION 355 0.0574
78 DEEP VEIN THROMBOSIS POSTOPERATIVE 115 0.0574
79 BACK INJURY 618 0.0568
80 X-RAY ABNORMAL 99 0.0553
81 APPLICATION SITE INFECTION 28 0.0550
82 GRIP STRENGTH DECREASED 483 0.0548
83 EXPULSION OF MEDICATION 28 0.0529
84 OVERDOSE 11035 0.0511
85 DRUG USE DISORDER 430 0.0511
86 INJECTION SITE INFECTION 168 0.0511
87 INJECTION SITE NECROSIS 103 0.0505
88 APPLICATION SITE BRUISE 48 0.0493
89 DISLOCATION OF VERTEBRA 112 0.0491
90 PLACENTAL DISORDER 46 0.0486
91 INJECTION SITE CELLULITIS 89 0.0478
92 APPLICATION SITE EXFOLIATION 195 0.0473
93 PERICARDITIS 792 0.0471
94 CONGENITAL ANOMALY 364 0.0470
95 DRUG ABUSE 3891 0.0467
96 MYELOPATHY 88 0.0463
97 NEURODEGENERATIVE DISORDER 28 0.0454
98 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94 0.0453
99 EMOTIONAL DISTRESS 5459 0.0450
100 APPLICATION SITE SCAB 97 0.0449
101 JOINT RANGE OF MOTION DECREASED 602 0.0448
102 SYNOVITIS 792 0.0439
103 VICTIM OF SEXUAL ABUSE 23 0.0437
104 URINARY TRACT DISORDER 195 0.0433
105 APPLICATION SITE PAIN 944 0.0428
106 DEVELOPMENTAL DELAY 386 0.0427
107 COELIAC DISEASE 417 0.0425
108 SWOLLEN JOINT COUNT INCREASED 134 0.0420
109 APPLICATION SITE PAPULES 44 0.0415
110 DRUG TOLERANCE 210 0.0415
111 SUBSTANCE DEPENDENCE 27 0.0401
112 INJECTION SITE ABSCESS 99 0.0397
113 SPINA BIFIDA 82 0.0393
114 APPLICATION SITE INFLAMMATION 54 0.0390
115 OBESITY 612 0.0384
116 DRUG ADMINISTERED AT INAPPROPRIATE SITE 404 0.0383
117 APPLICATION SITE DRYNESS 128 0.0377
118 TASTE DISORDER 759 0.0374
119 MIOSIS 297 0.0370
120 PORPHYRIA ACUTE 52 0.0362
121 NEONATAL RESPIRATORY DISTRESS 34 0.0361
122 EUPHORIC MOOD 365 0.0356
123 GLOSSODYNIA 790 0.0353
124 QUADRIPARESIS 58 0.0349
125 PRODUCT PHYSICAL CONSISTENCY ISSUE 192 0.0347
126 DEFAECATION DISORDER 23 0.0343
127 ALCOHOL ABUSE 91 0.0340
128 BONE EROSION 120 0.0339
129 THERAPEUTIC RESPONSE INCREASED 31 0.0330
130 FIBROMYALGIA 785 0.0323
131 DRUG SCREEN POSITIVE 252 0.0319
132 APPLICATION SITE HAEMORRHAGE 87 0.0318
133 APPLICATION SITE SWELLING 158 0.0317
134 DRUG EFFECT DECREASED 1691 0.0314
135 APPLICATION SITE WARMTH 40 0.0313
136 EPILEPSY 947 0.0309
137 SUBSTANCE USE 48 0.0307
138 IRRITABLE BOWEL SYNDROME 643 0.0300
139 RESPIRATORY DEPRESSION 363 0.0296
140 YAWNING 77 0.0288
141 WOUND 794 0.0284
142 EXPOSURE VIA BREAST MILK 113 0.0283
143 HAEMORRHAGIC STROKE 221 0.0283
144 BRADYPNOEA 76 0.0281
145 LIVER INJURY 690 0.0281
146 RETINITIS 46 0.0266
147 NORMAL NEWBORN 142 0.0261
148 MULTIPLE CONGENITAL ABNORMALITIES 37 0.0257
149 ADVERSE REACTION 340 0.0256
150 ACCIDENTAL OVERDOSE 919 0.0251
151 POST-TRAUMATIC STRESS DISORDER 164 0.0244
152 WITHDRAWAL SYNDROME 1026 0.0244
153 TYPE 2 DIABETES MELLITUS 819 0.0243
154 SYSTEMIC LUPUS ERYTHEMATOSUS 858 0.0241
155 PRODUCT CONTAMINATION 85 0.0239
156 JAUNDICE NEONATAL 45 0.0238
157 PILOERECTION 26 0.0237
158 CONTRAINDICATED PRODUCT ADMINISTERED 717 0.0237
159 SELF ESTEEM DECREASED 57 0.0235
160 APPLICATION SITE DISCOMFORT 42 0.0234
161 LIVER FUNCTION TEST INCREASED 487 0.0227
162 BREECH PRESENTATION 28 0.0222
163 VICTIM OF CRIME 27 0.0218
164 RHEUMATOID FACTOR POSITIVE 123 0.0213
165 C-REACTIVE PROTEIN INCREASED 771 0.0212
166 PSORIATIC ARTHROPATHY 857 0.0211
167 DENTAL CARIES 232 0.0210
168 ASPHYXIA 171 0.0209
169 MATERNAL EXPOSURE DURING PREGNANCY 1855 0.0208
170 SKIN REACTION 293 0.0208
171 APPLICATION SITE PARAESTHESIA 27 0.0207
172 COMPARTMENT SYNDROME 54 0.0207
173 HEPATITIS C 247 0.0204
174 IMPAIRED HEALING 671 0.0204
175 DISABILITY 403 0.0204
176 MICROCEPHALY 26 0.0203
177 NIGHT SWEATS 624 0.0193
178 HYPERAESTHESIA 158 0.0192
179 GAIT INABILITY 637 0.0190
180 ALCOHOL INTERACTION 37 0.0190
181 HOMICIDE 35 0.0190
182 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 320 0.0186
183 ACCIDENTAL DEATH 34 0.0183
184 IMPRISONMENT 32 0.0181
185 GENERALISED OEDEMA 221 0.0178
186 OCULAR DISCOMFORT 198 0.0176
187 AUTOIMMUNE DISORDER 171 0.0175
188 BLISTER 949 0.0169
189 FOETAL EXPOSURE DURING PREGNANCY 1347 0.0166
190 DRUG-INDUCED LIVER INJURY 519 0.0165
191 HEPATITIS 421 0.0164
192 DERMATITIS CONTACT 187 0.0164
193 OSTEOARTHRITIS 689 0.0162
194 LOWER RESPIRATORY TRACT INFECTION 731 0.0161
195 ECHOCARDIOGRAM ABNORMAL 22 0.0157
196 LOGORRHOEA 55 0.0156
197 DEATH 13443 0.0156
198 FOETAL DISTRESS SYNDROME 33 0.0155
199 BLOOD CHOLESTEROL INCREASED 721 0.0155
200 INFLAMMATION 798 0.0154
201 SEDATION 404 0.0154
202 CLUSTER HEADACHE 21 0.0154
203 THERAPEUTIC PRODUCT EFFECT DECREASED 688 0.0153
204 GUN SHOT WOUND 29 0.0153
205 BREAST CANCER STAGE II 127 0.0152
206 LABELLED DRUG-DRUG INTERACTION ISSUE 22 0.0152
207 ARTHROPATHY 845 0.0152
208 PERSECUTORY DELUSION 37 0.0148
209 ULCER HAEMORRHAGE 98 0.0145
210 JUDGEMENT IMPAIRED 21 0.0144
211 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37 0.0141
212 EXPOSURE DURING PREGNANCY 872 0.0140
213 THERAPEUTIC RESPONSE DELAYED 39 0.0139
214 ALTERED STATE OF CONSCIOUSNESS 301 0.0139
215 PAIN 8379 0.0136
216 INJECTION SITE OEDEMA 23 0.0134
217 DRUG INTOLERANCE 1293 0.0134
218 LUNG DISORDER 655 0.0134
219 MATERNAL EXPOSURE TIMING UNSPECIFIED 50 0.0133
220 IMPAIRED DRIVING ABILITY 151 0.0133
221 THERMAL BURN 94 0.0132
222 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21 0.0131
223 EXOSTOSIS 119 0.0130
224 PSYCHOMOTOR SKILLS IMPAIRED 34 0.0130
225 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 29 0.0130
226 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 79 0.0128
227 SKIN IRRITATION 585 0.0128
228 HEAD DISCOMFORT 226 0.0128
229 MENTAL DISORDER 553 0.0127
230 WRONG TECHNIQUE IN DRUG USAGE PROCESS 461 0.0127
231 GENERAL PHYSICAL CONDITION ABNORMAL 86 0.0127
232 INJECTION SITE EXTRAVASATION 156 0.0126
233 BRAIN OEDEMA 159 0.0126
234 WHEEZING 744 0.0125
235 STOMATITIS 759 0.0125
236 PRODUCT COLOUR ISSUE 64 0.0125
237 HYPOPNOEA 43 0.0124
238 SMALL FOR DATES BABY 61 0.0123
239 INTENTIONAL PRODUCT USE ISSUE 1072 0.0122
240 INFUSION RELATED REACTION 811 0.0122
241 GASTROOESOPHAGEAL REFLUX DISEASE 978 0.0121
242 CLUMSINESS 33 0.0121
243 EXTRA DOSE ADMINISTERED 487 0.0120
244 INJURY 843 0.0120
245 PRODUCT PHYSICAL ISSUE 239 0.0118
246 EXPOSURE DURING BREAST FEEDING 39 0.0118
247 NECK PAIN 649 0.0116
248 DRY MOUTH 936 0.0115
249 HAEMATEMESIS 292 0.0115
250 CLEFT PALATE 22 0.0114
251 MUSCULOSKELETAL PAIN 595 0.0113
252 PUSTULAR PSORIASIS 39 0.0113
253 INJECTION SITE DISCHARGE 61 0.0113
254 TOOTH LOSS 235 0.0113
255 MEDICATION RESIDUE PRESENT 54 0.0113
256 RASH VESICULAR 54 0.0112
257 HEPATIC ENZYME INCREASED 760 0.0111
258 PRODUCT PACKAGING DIFFICULT TO OPEN 29 0.0111
259 BEHAVIOUR DISORDER 60 0.0111
260 PHOTOPHOBIA 208 0.0110
261 DRUG TOLERANCE DECREASED 31 0.0110
262 INTENTIONAL PRODUCT MISUSE 964 0.0110
263 BLOOD PRESSURE DIASTOLIC ABNORMAL 28 0.0110
264 HYPERCAPNIA 33 0.0109
265 POISONING 137 0.0109
266 SLEEP DISORDER 766 0.0108
267 TONGUE DISCOMFORT 46 0.0108
268 ALCOHOL POISONING 29 0.0108
269 FEELING OF BODY TEMPERATURE CHANGE 63 0.0107
270 COMA 511 0.0107
271 RED BLOOD CELL SEDIMENTATION RATE INCREASED 115 0.0104
272 PRODUCT DISPENSING ISSUE 44 0.0103
273 CONFUSIONAL STATE 1661 0.0103
274 HYPERHIDROSIS 1314 0.0102
275 SEDATION COMPLICATION 26 0.0102
276 RESPIRATORY RATE DECREASED 32 0.0102
277 PRESCRIBED OVERDOSE 197 0.0102
278 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66 0.0102
279 ENDOCARDITIS 52 0.0101
280 TOOTH INJURY 44 0.0101
281 INJECTION SITE INFLAMMATION 50 0.0100
282 DEAFNESS NEUROSENSORY 33 0.0100
283 PRESYNCOPE 239 0.0098
284 GENERAL PHYSICAL HEALTH DETERIORATION 1137 0.0098
285 MIGRAINE 938 0.0098
286 POISONING DELIBERATE 92 0.0097
287 MOBILITY DECREASED 689 0.0096
288 TOOTH FRACTURE 105 0.0095
289 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40 0.0095
290 DERMATITIS ALLERGIC 119 0.0095
291 CARDIO-RESPIRATORY ARREST 390 0.0093
292 DIPLOPIA 241 0.0093
293 LUPUS-LIKE SYNDROME 84 0.0093
294 POTENTIATING DRUG INTERACTION 31 0.0092
295 INJECTION SITE REACTION 633 0.0092
296 SWELLING 850 0.0091
297 BRAIN INJURY 91 0.0091
298 SEROTONIN SYNDROME 173 0.0090
299 DELIRIUM 311 0.0090
300 STRESS CARDIOMYOPATHY 52 0.0089
301 LOW BIRTH WEIGHT BABY 71 0.0089
302 SCIATICA 142 0.0089
303 ROAD TRAFFIC ACCIDENT 370 0.0088
304 URINARY HESITATION 21 0.0088
305 SOMNOLENCE 1746 0.0087
306 WALKING AID USER 57 0.0086
307 INJECTION SITE INDURATION 112 0.0086
308 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 607 0.0085
309 ORAL DISCOMFORT 118 0.0085
310 MENTAL IMPAIRMENT 204 0.0084
311 ANXIETY DISORDER 28 0.0084
312 PRODUCT SIZE ISSUE 45 0.0084
313 INCOHERENT 54 0.0083
314 PREMATURE DELIVERY 132 0.0083
315 ILL-DEFINED DISORDER 502 0.0083
316 EYE INJURY 25 0.0082
317 ELECTRIC SHOCK SENSATION 23 0.0082
318 DEPRESSION 1866 0.0082
319 QUALITY OF LIFE DECREASED 110 0.0082
320 LOWER LIMB FRACTURE 157 0.0082
321 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 149 0.0081
322 PARANOIA 139 0.0081
323 FOETAL GROWTH RESTRICTION 49 0.0081
324 SPINAL STENOSIS 33 0.0080
325 THERAPEUTIC RESPONSE SHORTENED 265 0.0080
326 RHEUMATOID ARTHRITIS 900 0.0079
327 DYSPHORIA 40 0.0079
328 NECK INJURY 23 0.0078
329 HYPOAESTHESIA 1164 0.0078
330 SOMNAMBULISM 51 0.0078
331 INJECTION SITE SCAR 22 0.0077
332 MAJOR DEPRESSION 56 0.0077
333 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 52 0.0076
334 SPINAL FUSION SURGERY 31 0.0076
335 AFFECTIVE DISORDER 60 0.0076
336 LOSS OF EMPLOYMENT 23 0.0076
337 MONOPLEGIA 33 0.0076
338 UNEVALUABLE EVENT 574 0.0076
339 COMMUNICATION DISORDER 29 0.0076
340 RESTLESS LEGS SYNDROME 136 0.0075
341 TOXIC ENCEPHALOPATHY 37 0.0073
342 CRANIOCEREBRAL INJURY 22 0.0073
343 FEELING DRUNK 54 0.0073
344 INTENTIONAL UNDERDOSE 53 0.0072
345 COMA SCALE ABNORMAL 21 0.0072
346 MEMORY IMPAIRMENT 994 0.0072
347 ASCITES 212 0.0072
348 IMPAIRED WORK ABILITY 154 0.0072
349 TREATMENT FAILURE 595 0.0072
350 TOOTHACHE 130 0.0072
351 IMPAIRED QUALITY OF LIFE 101 0.0070
352 ALCOHOLISM 30 0.0070
353 HEPATIC FIBROSIS 24 0.0070
354 UNRESPONSIVE TO STIMULI 180 0.0070
355 BRADYKINESIA 41 0.0069
356 INJECTION SITE VESICLES 42 0.0069
357 TACHYPHRENIA 24 0.0069
358 HALLUCINATION 522 0.0069
359 BLINDNESS 282 0.0069
360 THERAPEUTIC RESPONSE DECREASED 418 0.0069
361 SPONDYLITIS 25 0.0069
362 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 489 0.0069
363 ASPIRATION 75 0.0068
364 GASTROINTESTINAL DISORDER 613 0.0068
365 EAR PAIN 133 0.0068
366 DYSARTHRIA 256 0.0068
367 HEPATIC CIRRHOSIS 127 0.0068
368 TINNITUS 310 0.0067
369 HAEMATURIA 231 0.0067
370 PARAESTHESIA 1060 0.0067
371 JOINT SWELLING 811 0.0067
372 PRODUCT QUALITY ISSUE 909 0.0067
373 MUSCULAR WEAKNESS 743 0.0065
374 AMNESIA 424 0.0065
375 TONGUE ULCERATION 22 0.0065
376 ABDOMINAL PAIN UPPER 1339 0.0065
377 DYSPEPSIA 638 0.0065
378 MUSCULOSKELETAL STIFFNESS 565 0.0064
379 ANXIETY 1830 0.0064
380 INJECTION SITE HYPERSENSITIVITY 20 0.0064
381 MYDRIASIS 82 0.0064
382 BIPOLAR DISORDER 69 0.0063
383 RESTLESSNESS 232 0.0063
384 HYPERREFLEXIA 22 0.0063
385 ABDOMINAL DISCOMFORT 1050 0.0063
386 PRE-EXISTING CONDITION IMPROVED 39 0.0062
387 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1259 0.0062
388 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 297 0.0062
389 AGGRESSION 309 0.0062
390 DRUG INTERACTION 979 0.0062
391 TACHYCARDIA 548 0.0062
392 SKIN ABRASION 29 0.0061
393 PERSONALITY CHANGE 57 0.0061
394 DISORIENTATION 242 0.0061
395 PULMONARY FIBROSIS 117 0.0061
396 MOUTH SWELLING 35 0.0061
397 PRODUCT FORMULATION ISSUE 40 0.0061
398 RASH 2626 0.0060
399 CONJUNCTIVAL HAEMORRHAGE 23 0.0060
400 DEPRESSED LEVEL OF CONSCIOUSNESS 238 0.0060
401 PRODUCT ADMINISTRATION INTERRUPTED 47 0.0060
402 PRURITUS GENERALISED 129 0.0060
403 NAUSEA 4712 0.0059
404 RESPIRATORY ARREST 164 0.0059
405 PREMATURE BABY 179 0.0059
406 PANIC DISORDER 23 0.0059
407 PRODUCT TASTE ABNORMAL 80 0.0059
408 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 100 0.0059
409 DISCOMFORT 359 0.0059
410 BEDRIDDEN 77 0.0059
411 RESPIRATORY ACIDOSIS 23 0.0058
412 COLD SWEAT 103 0.0058
413 PULMONARY CONGESTION 77 0.0058
414 RHABDOMYOLYSIS 243 0.0058
415 FOETAL DEATH 30 0.0058
416 INCORRECT PRODUCT ADMINISTRATION DURATION 125 0.0058
417 SUICIDAL BEHAVIOUR 24 0.0058
418 PRESCRIBED UNDERDOSE 115 0.0058
419 PERIPHERAL SWELLING 879 0.0057
420 PRODUCT ADMINISTRATION ERROR 115 0.0057
421 PNEUMONIA ASPIRATION 142 0.0057
422 DIZZINESS 2822 0.0057
423 FAECALOMA 31 0.0057
424 NEONATAL RESPIRATORY DISTRESS SYNDROME 20 0.0056
425 SUICIDAL IDEATION 517 0.0056
426 INSOMNIA 1498 0.0056
427 OVERWEIGHT 30 0.0056
428 AGITATION 406 0.0055
429 PULMONARY OEDEMA 246 0.0055
430 HOMICIDAL IDEATION 22 0.0054
431 VOMITING 2549 0.0054
432 INJECTION SITE IRRITATION 69 0.0054
433 BODY TEMPERATURE DECREASED 53 0.0054
434 HEART RATE ABNORMAL 30 0.0054
435 BRADYPHRENIA 35 0.0054
436 SOCIAL AVOIDANT BEHAVIOUR 31 0.0054
437 BONE DENSITY ABNORMAL 20 0.0053
438 URTICARIA 895 0.0053
439 DRUG EFFECT LESS THAN EXPECTED 79 0.0053
440 ABDOMINAL DISTENSION 556 0.0053
441 URINARY RETENTION 176 0.0053
442 PRE-ECLAMPSIA 25 0.0053
443 HALLUCINATIONS, MIXED 22 0.0052
444 FORMICATION 36 0.0052
445 MUSCLE SPASMS 948 0.0052
446 FEELING OF DESPAIR 24 0.0051
447 SUSPECTED SUICIDE 24 0.0051
448 DISTURBANCE IN ATTENTION 276 0.0051
449 SUSPECTED OFF LABEL USE 23 0.0051
450 DELUSION 79 0.0051
451 LETHARGY 292 0.0051
452 HYPERTONIA 29 0.0051
453 BLOOD PRESSURE SYSTOLIC DECREASED 23 0.0051
454 CACHEXIA 26 0.0050
455 PRODUCT PACKAGING ISSUE 48 0.0050
456 MUSCLE RIGIDITY 60 0.0050
457 DEPENDENCE 274 0.0050
458 COGNITIVE DISORDER 233 0.0050
459 TORSADE DE POINTES 39 0.0050
460 HIP ARTHROPLASTY 76 0.0050
461 DRUG INEFFECTIVE 6528 0.0049
462 MYOCLONUS 59 0.0049
463 APNOEA 38 0.0049
464 HALLUCINATION, VISUAL 103 0.0049
465 HYPERTENSION 1032 0.0049
466 PRODUCT TEMPERATURE EXCURSION ISSUE 25 0.0049
467 PRODUCT PRESCRIBING ISSUE 106 0.0049
468 SUICIDE ATTEMPT 295 0.0049
469 PRODUCT SUBSTITUTION ISSUE 280 0.0049
470 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
471 DRUG EFFECT DELAYED 22 0.0048
472 BRUXISM 26 0.0048
473 PRODUCT PRESCRIBING ERROR 114 0.0048
474 ABNORMAL BEHAVIOUR 189 0.0048
475 RESPIRATORY DISORDER 142 0.0047
476 TOOTH DISORDER 105 0.0047
477 SCREAMING 30 0.0047
478 ABNORMAL LOSS OF WEIGHT 32 0.0047
479 SPINAL OPERATION 57 0.0046
480 HYPERTHERMIA 35 0.0046
481 SLEEP APNOEA SYNDROME 87 0.0046
482 FEELING JITTERY 86 0.0045
483 CONSTIPATION 984 0.0045
484 THINKING ABNORMAL 84 0.0045
485 JOINT STIFFNESS 118 0.0045
486 HYPERVENTILATION 26 0.0045
487 ALOPECIA 880 0.0045
488 PSYCHOTIC DISORDER 132 0.0045
489 FEELING ABNORMAL 1071 0.0045
490 OEDEMA 241 0.0044
491 SCHIZOPHRENIA 54 0.0044
492 HALLUCINATION, AUDITORY 70 0.0044
493 ACCIDENT 52 0.0044
494 JOINT DISLOCATION 46 0.0043
495 MYOSITIS 39 0.0043
496 NERVE INJURY 48 0.0043
497 NASOPHARYNGITIS 788 0.0043
498 SKIN NECROSIS 22 0.0042
499 DECREASED INTEREST 25 0.0042
500 ANGER 143 0.0042
501 CARDIOMEGALY 52 0.0042
502 PRODUCT USE ISSUE 794 0.0042
503 MATERNAL DRUGS AFFECTING FOETUS 32 0.0042
504 SYNCOPE 417 0.0042
505 HYPERSOMNIA 119 0.0041
506 CHILLS 486 0.0041
507 APATHY 60 0.0041
508 OEDEMA PERIPHERAL 499 0.0041
509 ASTHENIA 1537 0.0041
510 DEVICE LEAKAGE 177 0.0041
511 CONDITION AGGRAVATED 1240 0.0041
512 EYE PAIN 230 0.0041
513 CYANOSIS 64 0.0041
514 BLOOD PRESSURE DIASTOLIC DECREASED 30 0.0041
515 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
516 HEADACHE 2482 0.0040
517 BLOOD TESTOSTERONE DECREASED 27 0.0039
518 FALL 1313 0.0039
519 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 710 0.0039
520 GINGIVITIS 21 0.0039
521 INTERVERTEBRAL DISC DEGENERATION 36 0.0039
522 WEIGHT INCREASED 871 0.0039
523 RESPIRATORY DISTRESS 107 0.0039
524 PRODUCT USE COMPLAINT 61 0.0039
525 HYPOTHERMIA 39 0.0038
526 FAECES SOFT 28 0.0038
527 SEXUAL DYSFUNCTION 45 0.0038
528 CARDIAC DISORDER 358 0.0038
529 LOSS OF CONSCIOUSNESS 490 0.0038
530 RASH GENERALISED 99 0.0038
531 DECREASED APPETITE 875 0.0038
532 SPINAL OSTEOARTHRITIS 33 0.0038
533 SPINAL PAIN 44 0.0038
534 PRODUCT USE IN UNAPPROVED INDICATION 930 0.0037
535 PANIC REACTION 27 0.0037
536 GENERAL SYMPTOM 28 0.0037
537 HYPERSENSITIVITY 693 0.0037
538 PRODUCT ODOUR ABNORMAL 39 0.0037
539 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
540 PRODUCT DISPENSING ERROR 80 0.0037
541 DEMENTIA 102 0.0036
542 DRUG LEVEL DECREASED 37 0.0036
543 DRUG LEVEL INCREASED 60 0.0036
544 PHARYNGITIS STREPTOCOCCAL 39 0.0036
545 SUDDEN DEATH 38 0.0036
546 SPUTUM DISCOLOURED 34 0.0036
547 MALNUTRITION 40 0.0036
548 MALAISE 1568 0.0036
549 LIVER DISORDER 158 0.0036
550 ENERGY INCREASED 21 0.0036
551 ARTHRALGIA 1470 0.0035
552 IMPAIRED GASTRIC EMPTYING 48 0.0035
553 BACK DISORDER 57 0.0035
554 NEURALGIA 85 0.0035
555 SENSORY DISTURBANCE 56 0.0035
556 PANIC ATTACK 127 0.0035
557 ARTERIOSCLEROSIS CORONARY ARTERY 23 0.0035
558 UROSEPSIS 32 0.0035
559 LOSS OF LIBIDO 31 0.0034
560 SCAR 59 0.0034
561 NIGHTMARE 119 0.0034
562 MUSCLE TWITCHING 79 0.0034
563 COMPLETED SUICIDE 285 0.0034
564 DRUG ABUSER 21 0.0034
565 UNDERDOSE 249 0.0034
566 IRRITABILITY 205 0.0034
567 GINGIVAL PAIN 27 0.0034
568 MOOD SWINGS 108 0.0034
569 CONTUSION 326 0.0034
570 ENCEPHALOPATHY 83 0.0034
571 CEREBRAL DISORDER 25 0.0034
572 FACIAL PAIN 30 0.0034
573 INJECTION SITE WARMTH 69 0.0034
574 INJECTION SITE PAIN 1026 0.0033
575 DYSURIA 123 0.0033
576 SEIZURE 385 0.0033
577 SEPSIS 370 0.0033
578 ERECTILE DYSFUNCTION 85 0.0033
579 PRODUCT COMMUNICATION ISSUE 29 0.0033
580 KNEE ARTHROPLASTY 69 0.0033
581 INTENTIONAL SELF-INJURY 66 0.0033
582 BRAIN FOG 51 0.0033
583 ADVERSE DRUG REACTION 292 0.0032
584 SOPOR 43 0.0032
585 LIP SWELLING 108 0.0032
586 ABDOMINAL PAIN 753 0.0032
587 DYSPNOEA 1830 0.0032
588 COORDINATION ABNORMAL 45 0.0032
589 PRURITUS 1221 0.0032
590 NO ADVERSE EVENT 574 0.0032
591 LOCAL SWELLING 55 0.0031
592 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
593 ADVERSE EVENT 290 0.0031
594 PREGNANCY 63 0.0031
595 ILLNESS 323 0.0031
596 PNEUMONIA 1011 0.0031
597 SENSITIVE SKIN 23 0.0031
598 ORTHOSTATIC HYPOTENSION 54 0.0031
599 TREMOR 514 0.0031
600 INJECTION SITE ERYTHEMA 384 0.0031
601 DIZZINESS POSTURAL 30 0.0031
602 MEDICATION ERROR 170 0.0031
603 THERAPY NON-RESPONDER 137 0.0030
604 PAIN IN EXTREMITY 898 0.0030
605 DROOLING 21 0.0030
606 URINARY INCONTINENCE 90 0.0030
607 FEELING HOT 186 0.0030
608 POOR QUALITY SLEEP 65 0.0030
609 CAESAREAN SECTION 35 0.0030
610 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
611 MENTAL STATUS CHANGES 83 0.0030
612 PALPITATIONS 350 0.0030
613 FOOT DEFORMITY 33 0.0030
614 INTENTIONAL OVERDOSE 190 0.0030
615 IMMUNE SYSTEM DISORDER 39 0.0030
616 OSTEOPOROSIS 121 0.0029
617 MUSCLE SPASTICITY 36 0.0029
618 INJECTION SITE NODULE 32 0.0029
619 HYPOTONIA 29 0.0029
620 SALIVARY HYPERSECRETION 29 0.0029
621 HYPOXIA 102 0.0029
622 TOOTH EXTRACTION 36 0.0029
623 SWOLLEN TONGUE 89 0.0028
624 BLOOD PRESSURE INCREASED 435 0.0028
625 GASTRIC ULCER 54 0.0028
626 INJECTION SITE MASS 105 0.0028
627 RIB FRACTURE 58 0.0028
628 HYDRONEPHROSIS 21 0.0028
629 FEELING COLD 78 0.0028
630 INJECTION SITE DISCOMFORT 29 0.0028
631 TOOTH ABSCESS 28 0.0027
632 ORAL DISORDER 20 0.0027
633 BURNING SENSATION 191 0.0027
634 CHEST PAIN 503 0.0027
635 ACUTE RESPIRATORY DISTRESS SYNDROME 48 0.0027
636 FREQUENT BOWEL MOVEMENTS 73 0.0027
637 FOOT FRACTURE 51 0.0027
638 MYALGIA 457 0.0027
639 TENDERNESS 28 0.0027
640 MUSCLE ATROPHY 34 0.0027
641 INTENTIONAL DRUG MISUSE 56 0.0027
642 CARDIAC ARREST 221 0.0027
643 HOSPITALISATION 410 0.0027
644 FATIGUE 2075 0.0027
645 TACHYPNOEA 36 0.0026
646 BLOOD ALBUMIN DECREASED 21 0.0026
647 INJECTION SITE DISCOLOURATION 33 0.0026
648 OFF LABEL USE 2311 0.0026
649 SCAB 30 0.0026
650 DEPRESSED MOOD 139 0.0026
651 OXYGEN SATURATION DECREASED 147 0.0026
652 CRYING 95 0.0026
653 DEVICE ADHESION ISSUE 40 0.0026
654 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
655 POLYNEUROPATHY 31 0.0026
656 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 135 0.0026
657 WEIGHT FLUCTUATION 27 0.0026
658 MOOD ALTERED 70 0.0026
659 POOR QUALITY PRODUCT ADMINISTERED 27 0.0026
660 MANIA 42 0.0026
661 HYPOKINESIA 37 0.0025
662 VISION BLURRED 349 0.0025
663 GENERALISED TONIC-CLONIC SEIZURE 42 0.0025
664 CHROMATURIA 57 0.0025
665 DIARRHOEA 1625 0.0025
666 INJECTION SITE PRURITUS 168 0.0025
667 CARPAL TUNNEL SYNDROME 35 0.0025
668 BLOOD DISORDER 20 0.0025
669 SKIN INFECTION 28 0.0025
670 AFFECT LABILITY 24 0.0025
671 NERVOUSNESS 130 0.0025
672 ASTHMA 281 0.0025
673 SKIN LACERATION 27 0.0025
674 DRUG EFFECT INCOMPLETE 90 0.0025
675 SINUS TACHYCARDIA 35 0.0025
676 SCRATCH 26 0.0025
677 ARTERIOSCLEROSIS 23 0.0024
678 EAR INFECTION 65 0.0024
679 THERAPY CHANGE 24 0.0024
680 ANKYLOSING SPONDYLITIS 32 0.0024
681 BALANCE DISORDER 208 0.0024
682 HOT FLUSH 181 0.0024
683 DYSSTASIA 70 0.0024
684 DRUG PRESCRIBING ERROR 46 0.0024
685 INJECTION SITE SWELLING 183 0.0024
686 HYPOAESTHESIA ORAL 36 0.0024
687 ATRIAL SEPTAL DEFECT 20 0.0024
688 TRANSFUSION 25 0.0024
689 LACRIMATION INCREASED 72 0.0024
690 IMMUNOSUPPRESSION 21 0.0024
691 VERTIGO 144 0.0024
692 ATAXIA 28 0.0024
693 NEPHROPATHY 22 0.0024
694 HEART RATE IRREGULAR 53 0.0023
695 ANAL INCONTINENCE 21 0.0023
696 BLOOD PRESSURE FLUCTUATION 56 0.0023
697 DYSKINESIA 93 0.0023
698 NERVOUS SYSTEM DISORDER 71 0.0023
699 EMOTIONAL DISORDER 70 0.0023
700 SURGERY 132 0.0022
701 ECONOMIC PROBLEM 34 0.0022
702 GAIT DISTURBANCE 429 0.0022
703 ACUTE KIDNEY INJURY 343 0.0022
704 BACK PAIN 520 0.0022
705 HYPOKALAEMIA 103 0.0022
706 TEMPERATURE INTOLERANCE 23 0.0022
707 ABORTION SPONTANEOUS 89 0.0022
708 PARAESTHESIA ORAL 32 0.0022
709 INFECTION 321 0.0022
710 OSTEOMYELITIS 40 0.0022
711 CELLULITIS 111 0.0022
712 JOINT INJURY 47 0.0022
713 MICTURITION URGENCY 25 0.0022
714 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
715 SWELLING FACE 142 0.0022
716 FULL BLOOD COUNT ABNORMAL 23 0.0022
717 CIRCULATORY COLLAPSE 37 0.0022
718 LIMB INJURY 59 0.0022
719 PRODUCT AVAILABILITY ISSUE 49 0.0021
720 HEAD INJURY 68 0.0021
721 ADRENAL INSUFFICIENCY 26 0.0021
722 HYPOTENSION 429 0.0021
723 MOUTH ULCERATION 45 0.0021
724 INFLUENZA LIKE ILLNESS 175 0.0021
725 HEART RATE INCREASED 210 0.0021
726 FEAR 57 0.0021
727 DYSTONIA 41 0.0021
728 BRADYCARDIA 112 0.0021
729 OSTEOPENIA 32 0.0021
730 INTERVERTEBRAL DISC PROTRUSION 46 0.0021
731 RHINORRHOEA 136 0.0021
732 HYPOGLYCAEMIA 102 0.0021
733 WEIGHT DECREASED 586 0.0021
734 SNEEZING 47 0.0021
735 METABOLIC ACIDOSIS 67 0.0021
736 SKIN LESION 57 0.0021
737 SINUS CONGESTION 28 0.0021
738 FEEDING DISORDER 42 0.0021
739 TREATMENT NONCOMPLIANCE 113 0.0021
740 GOUT 37 0.0021
741 DYSPHAGIA 195 0.0021
742 INJECTION SITE RASH 63 0.0021
743 TOOTH INFECTION 27 0.0020
744 INITIAL INSOMNIA 21 0.0020
745 SPINAL FRACTURE 41 0.0020
746 PERIPHERAL COLDNESS 28 0.0020
747 KNEE OPERATION 20 0.0020
748 CARDIOMYOPATHY 30 0.0020
749 WRIST FRACTURE 24 0.0020
750 RESPIRATORY TRACT INFECTION 52 0.0020
751 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
752 INTENTIONAL DOSE OMISSION 56 0.0020
753 MOVEMENT DISORDER 63 0.0020
754 INSURANCE ISSUE 30 0.0020
755 APHASIA 59 0.0020
756 DECREASED ACTIVITY 21 0.0019
757 LOCALISED INFECTION 47 0.0019
758 STAPHYLOCOCCAL INFECTION 64 0.0019
759 ANKLE FRACTURE 30 0.0019
760 RECTAL HAEMORRHAGE 83 0.0019
761 EATING DISORDER 41 0.0019
762 PYREXIA 663 0.0019
763 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
764 PARALYSIS 27 0.0019
765 ABNORMAL DREAMS 52 0.0019
766 HYPONATRAEMIA 106 0.0019
767 ABSCESS 30 0.0019
768 EYE HAEMORRHAGE 25 0.0019
769 PELVIC PAIN 34 0.0019
770 ACUTE RESPIRATORY FAILURE 36 0.0019
771 HUNGER 26 0.0019
772 SINUSITIS 191 0.0019
773 LIVER FUNCTION TEST ABNORMAL 54 0.0019
774 UPPER RESPIRATORY TRACT INFECTION 85 0.0018
775 PALLOR 50 0.0018
776 NEUROPATHY PERIPHERAL 174 0.0018
777 RETCHING 39 0.0018
778 SKIN DISORDER 61 0.0018
779 METASTASES TO BONE 30 0.0018
780 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 100 0.0018
781 PHARYNGEAL OEDEMA 28 0.0018
782 ARTHRITIS 143 0.0018
783 METASTASES TO LUNG 21 0.0018
784 ELECTROLYTE IMBALANCE 21 0.0018
785 WHITE BLOOD CELL COUNT INCREASED 69 0.0018
786 HYPOCALCAEMIA 34 0.0018
787 ARRHYTHMIA 85 0.0018
788 SMALL INTESTINAL OBSTRUCTION 22 0.0018
789 THERAPEUTIC RESPONSE UNEXPECTED 80 0.0018
790 SKIN ULCER 46 0.0018
791 THROAT TIGHTNESS 48 0.0018
792 PANCREATITIS 93 0.0018
793 ORAL CANDIDIASIS 23 0.0017
794 INJECTION SITE BRUISING 139 0.0017
795 ORAL PAIN 39 0.0017
796 HEART RATE DECREASED 61 0.0017
797 KIDNEY INFECTION 34 0.0017
798 PROCEDURAL PAIN 48 0.0017
799 HEPATIC CYTOLYSIS 22 0.0017
800 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
801 INTESTINAL OBSTRUCTION 64 0.0017
802 CHOKING 33 0.0017
803 ILEUS 21 0.0017
804 CHEST DISCOMFORT 172 0.0017
805 IMMUNODEFICIENCY 25 0.0017
806 BONE PAIN 97 0.0017
807 FLUID RETENTION 84 0.0016
808 ULCER 26 0.0016
809 HYPOTHYROIDISM 52 0.0016
810 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
811 LABORATORY TEST ABNORMAL 48 0.0016
812 RASH PRURITIC 88 0.0016
813 LIMB DISCOMFORT 50 0.0016
814 EXTRAPYRAMIDAL DISORDER 40 0.0016
815 ACUTE HEPATIC FAILURE 22 0.0016
816 RESPIRATORY FAILURE 116 0.0016
817 SPEECH DISORDER 83 0.0016
818 PNEUMOTHORAX 25 0.0016
819 DERMATITIS 33 0.0016
820 BODY TEMPERATURE INCREASED 32 0.0016
821 POLLAKIURIA 65 0.0016
822 LEUKOCYTOSIS 28 0.0015
823 NEUROTOXICITY 27 0.0015
824 CARDIOGENIC SHOCK 22 0.0015
825 FAECES DISCOLOURED 33 0.0015
826 COUGH 426 0.0015
827 DYSPHONIA 87 0.0015
828 VISUAL IMPAIRMENT 184 0.0015
829 SKIN BURNING SENSATION 106 0.0015
830 ERYTHEMA 303 0.0015
831 THERAPY CESSATION 75 0.0015
832 MELAENA 32 0.0015
833 URINARY TRACT INFECTION 247 0.0014
834 PRODUCT DOSE OMISSION IN ERROR 41 0.0014
835 ANGINA PECTORIS 41 0.0014
836 LEUKOPENIA 71 0.0014
837 RENAL IMPAIRMENT 119 0.0014
838 HYPOPHAGIA 36 0.0014
839 DEHYDRATION 187 0.0014
840 PNEUMONITIS 38 0.0014
841 MUSCULOSKELETAL DISCOMFORT 24 0.0014
842 HAEMORRHOIDS 27 0.0014
843 BRONCHITIS 102 0.0014
844 FRACTURE 26 0.0014
845 MUSCLE TIGHTNESS 22 0.0014
846 MUSCULOSKELETAL CHEST PAIN 21 0.0014
847 SEPTIC SHOCK 59 0.0014
848 RENAL DISORDER 63 0.0014
849 NEPHROLITHIASIS 62 0.0014
850 ISCHAEMIC STROKE 24 0.0013
851 CARDIAC FAILURE 107 0.0013
852 CHRONIC KIDNEY DISEASE 101 0.0013
853 HEPATIC FAILURE 40 0.0013
854 BLOOD PRESSURE DECREASED 87 0.0013
855 PRODUCT COMPLAINT 33 0.0013
856 ANHEDONIA 34 0.0013
857 BLOOD POTASSIUM INCREASED 21 0.0013
858 DYSGEUSIA 96 0.0013
859 OROPHARYNGEAL PAIN 119 0.0013
860 MULTIPLE FRACTURES 21 0.0013
861 PHOTOSENSITIVITY REACTION 21 0.0013
862 JAUNDICE 34 0.0013
863 ATRIAL FIBRILLATION 123 0.0013
864 SINUS DISORDER 25 0.0013
865 TRANSAMINASES INCREASED 28 0.0013
866 INCREASED APPETITE 24 0.0013
867 ACUTE MYOCARDIAL INFARCTION 37 0.0013
868 GASTRITIS 33 0.0013
869 PULMONARY EMBOLISM 119 0.0013
870 DRUG ADMINISTRATION ERROR 37 0.0012
871 UPPER LIMB FRACTURE 24 0.0012
872 COAGULOPATHY 20 0.0012
873 PAIN IN JAW 34 0.0012
874 PULMONARY HYPERTENSION 25 0.0012
875 HAEMATOMA 31 0.0012
876 CHOLELITHIASIS 39 0.0012
877 PAIN OF SKIN 32 0.0012
878 COLITIS ULCERATIVE 53 0.0012
879 HIP FRACTURE 38 0.0012
880 GALLBLADDER DISORDER 21 0.0012
881 TARDIVE DYSKINESIA 33 0.0012
882 FEMUR FRACTURE 36 0.0012
883 DRY EYE 58 0.0012
884 RENAL FAILURE 154 0.0012
885 HEPATIC FUNCTION ABNORMAL 43 0.0012
886 END STAGE RENAL DISEASE 21 0.0012
887 CHOLESTASIS 22 0.0011
888 INJECTION SITE URTICARIA 28 0.0011
889 RASH ERYTHEMATOUS 54 0.0011
890 DEEP VEIN THROMBOSIS 73 0.0011
891 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
892 PRODUCT PREPARATION ERROR 23 0.0011
893 HYPERKALAEMIA 39 0.0011
894 GASTROENTERITIS VIRAL 20 0.0011
895 GASTRIC DISORDER 38 0.0011
896 DYSPNOEA EXERTIONAL 41 0.0011
897 SKIN DISCOLOURATION 50 0.0011
898 CARDIAC FAILURE CONGESTIVE 87 0.0011
899 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
900 OCULAR HYPERAEMIA 51 0.0011
901 RENAL FAILURE ACUTE 45 0.0011
902 PRODUCT DOSE OMISSION ISSUE 310 0.0011
903 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
904 MUSCULOSKELETAL DISORDER 20 0.0010
905 ANAPHYLACTIC REACTION 58 0.0010
906 CONVULSION 60 0.0010
907 AGEUSIA 26 0.0010
908 CEREBRAL HAEMORRHAGE 37 0.0010
909 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
910 INFLUENZA 112 0.0010
911 PLEURAL EFFUSION 61 0.0010
912 ANAEMIA 189 0.0010
913 HAEMATOCHEZIA 54 0.0010
914 EPISTAXIS 73 0.0010
915 DIVERTICULITIS 27 0.0010
916 ANGIOEDEMA 43 0.0010
917 ANAPHYLACTIC SHOCK 25 0.0010
918 CEREBROVASCULAR ACCIDENT 164 0.0010
919 FLUSHING 97 0.0010
920 FLATULENCE 54 0.0010
921 INCORRECT ROUTE OF DRUG ADMINISTRATION 34 0.0010
922 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
923 INCORRECT DOSE ADMINISTERED 214 0.0009
924 FUNGAL INFECTION 31 0.0009
925 PSORIASIS 121 0.0009
926 INCORRECT DRUG ADMINISTRATION DURATION 26 0.0009
927 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43 0.0009
928 RASH MACULAR 32 0.0009
929 EYE SWELLING 34 0.0009
930 HYPERGLYCAEMIA 33 0.0009
931 SKIN EXFOLIATION 76 0.0009
932 HAEMOPTYSIS 24 0.0009
933 PANCYTOPENIA 48 0.0009
934 THROMBOCYTOPENIA 96 0.0009
935 NEOPLASM MALIGNANT 57 0.0009
936 NASAL CONGESTION 50 0.0008
937 CYSTITIS 27 0.0008
938 MYOCARDIAL INFARCTION 147 0.0008
939 PRODUCT DOSE OMISSION 55 0.0008
940 PRODUCTIVE COUGH 40 0.0008
941 ACCIDENTAL EXPOSURE TO PRODUCT 86 0.0008
942 NEEDLE ISSUE 24 0.0008
943 ECZEMA 43 0.0008
944 THROMBOSIS 66 0.0008
945 THERAPY INTERRUPTED 58 0.0008
946 ABASIA 20 0.0008
947 RENAL INJURY 24 0.0008
948 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
949 COLITIS 30 0.0008
950 ABDOMINAL PAIN LOWER 20 0.0008
951 THROAT IRRITATION 35 0.0008
952 LYMPHADENOPATHY 27 0.0008
953 OSTEONECROSIS 25 0.0008
954 MULTIPLE SCLEROSIS 36 0.0008
955 BLOOD CREATININE INCREASED 47 0.0007
956 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21 0.0007
957 INJECTION SITE HAEMORRHAGE 57 0.0007
958 DEVICE MALFUNCTION 50 0.0007
959 PRODUCT STORAGE ERROR 62 0.0007
960 CORONARY ARTERY DISEASE 21 0.0007
961 EXPIRED PRODUCT ADMINISTERED 23 0.0007
962 VIRAL INFECTION 23 0.0007
963 COVID-19 121 0.0007
964 DIABETES MELLITUS 52 0.0007
965 HAEMORRHAGE 70 0.0007
966 EYE DISORDER 22 0.0007
967 BLOOD POTASSIUM DECREASED 20 0.0007
968 NEOPLASM PROGRESSION 23 0.0007
969 HERPES ZOSTER 38 0.0007
970 EYE PRURITUS 22 0.0007
971 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
972 HYPOACUSIS 28 0.0006
973 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
974 VAGINAL HAEMORRHAGE 26 0.0006
975 NEUTROPENIA 80 0.0006
976 CATARACT 35 0.0006
977 HAEMOGLOBIN DECREASED 59 0.0006
978 NEUTROPHIL COUNT DECREASED 22 0.0005
979 DRY SKIN 68 0.0005
980 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
981 DISEASE RECURRENCE 23 0.0005
982 BLOOD GLUCOSE DECREASED 23 0.0005
983 DISEASE PROGRESSION 54 0.0005
984 FEBRILE NEUTROPENIA 29 0.0004
985 DEVICE ISSUE 37 0.0004
986 PLATELET COUNT DECREASED 43 0.0004
987 ACNE 30 0.0004
988 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
989 BLOOD GLUCOSE INCREASED 58 0.0003
990 DRUG DOSE OMISSION 42 0.0003